Author： Devogelaer Jean-Pierre Manicourt Daniel H
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.16, 2007-11, pp. : 2863-2869
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Zoledronic Acid: A Review of its Use in the Treatment of Paget's Disease of Bone
By Keating Gillian M. Scott Lesley J.
Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. :
Access to resources
Recommend
Zoledronic acid: a guide to its use in Paget's disease of bone
Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. :
Zoledronic acid dominant option for Paget's disease
Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. :
Treatment of Patients with Paget's Disease of Bone
Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. :
Zoledronic acid dominant option for Paget's disease in Germany, Hungary
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :